Sodium-Glucose Cotransporter-2 Inhibitor Immediately Decreases Serum Uric Acid Levels in Type 2 Diabetic Patients

BACKGROUND: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are new antihyperglycemic drugs for type 2 diabetes. SGLT2 inhibitors ameliorate cardiovascular morbidity and mortality as well as kidney disease progression by reducing body weight (BW), blood pressure (BP), visceral adiposity, albuminur...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohashi, Naro, Aoki, Taro, Matsuyama, Takashi, Ishigaki, Sayaka, Isobe, Shinsuke, Fujikura, Tomoyuki, Hashimoto, Takuya, Tsuriya, Daisuke, Morita, Hiroshi, Kato, Akihiko, Yasuda, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537479/
https://www.ncbi.nlm.nih.gov/pubmed/33004785
http://dx.doi.org/10.12659/MSM.926086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537479/
https://www.ncbi.nlm.nih.gov/pubmed/33004785
http://dx.doi.org/10.12659/MSM.926086

Ejemplares similares